BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32017919)

  • 1. Small Molecule Inhibition of CPS1 Activity through an Allosteric Pocket.
    Yao S; Nguyen TV; Rolfe A; Agrawal AA; Ke J; Peng S; Colombo F; Yu S; Bouchard P; Wu J; Huang KC; Bao X; Omoto K; Selvaraj A; Yu L; Ioannidis S; Vaillancourt FH; Zhu P; Larsen NA; Bolduc DM
    Cell Chem Biol; 2020 Mar; 27(3):259-268.e5. PubMed ID: 32017919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the therapeutic potential of carbamoyl phosphate synthetase 1 (CPS1) in human diseases.
    Zhang L; Zou Y; Lu Y; Li Z; Gao F
    Bioorg Chem; 2023 Jan; 130():106253. PubMed ID: 36356370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency.
    Martínez AI; Pérez-Arellano I; Pekkala S; Barcelona B; Cervera J
    Mol Genet Metab; 2010 Dec; 101(4):311-23. PubMed ID: 20800523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of carbamoyl phosphate synthetase 1 reporter cell lines for the assessment of ammonia metabolism.
    Wang Y; Chang L; Zhai J; Wu Q; Wang D; Wang Y
    J Cell Mol Med; 2017 Dec; 21(12):3214-3223. PubMed ID: 28557353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 2,6-Dimethylpiperazines as Allosteric Inhibitors of CPS1.
    Rolfe A; Yao S; Nguyen TV; Omoto K; Colombo F; Virrankoski M; Vaillancourt FH; Yu L; Cook A; Reynolds D; Ioannidis S; Zhu P; Larsen NA; Bolduc DM
    ACS Med Chem Lett; 2020 Jun; 11(6):1305-1309. PubMed ID: 32551016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of carbamoyl phosphate synthetase 1 (CPS1) deficiency in Turkish patients: characterization of a founder mutation by use of recombinant CPS1 from insect cells expression.
    Hu L; Diez-Fernandez C; Rüfenacht V; Hismi BÖ; Ünal Ö; Soyucen E; Çoker M; Bayraktar BT; Gunduz M; Kiykim E; Olgac A; Pérez-Tur J; Rubio V; Häberle J
    Mol Genet Metab; 2014 Dec; 113(4):267-73. PubMed ID: 25410056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Study of Carbamoyl Phosphate Synthetase 1 Deficiency Sheds Light on the Mechanism for Switching On/Off the Urea Cycle.
    Díez-Fernández C; Gallego J; Häberle J; Cervera J; Rubio V
    J Genet Genomics; 2015 May; 42(5):249-60. PubMed ID: 26059772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of the carbamoyl phosphate synthase 1 promoter in human liver-derived cells is dependent on hepatocyte nuclear factor 3-beta.
    Chen Z; Tang N; Wang X; Chen Y
    J Cell Mol Med; 2017 Sep; 21(9):2036-2045. PubMed ID: 28272778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy.
    Khoja S; Nitzahn M; Hermann K; Truong B; Borzone R; Willis B; Rudd M; Palmer DJ; Ng P; Brunetti-Pierri N; Lipshutz GS
    Mol Genet Metab; 2018 Aug; 124(4):243-253. PubMed ID: 29801986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Split AAV-Mediated Gene Therapy Restores Ureagenesis in a Murine Model of Carbamoyl Phosphate Synthetase 1 Deficiency.
    Nitzahn M; Allegri G; Khoja S; Truong B; Makris G; Häberle J; Lipshutz GS
    Mol Ther; 2020 Jul; 28(7):1717-1730. PubMed ID: 32359471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells.
    Kim J; Hu Z; Cai L; Li K; Choi E; Faubert B; Bezwada D; Rodriguez-Canales J; Villalobos P; Lin YF; Ni M; Huffman KE; Girard L; Byers LA; Unsal-Kacmaz K; Peña CG; Heymach JV; Wauters E; Vansteenkiste J; Castrillon DH; Chen BPC; Wistuba I; Lambrechts D; Xu J; Minna JD; DeBerardinis RJ
    Nature; 2017 Jun; 546(7656):168-172. PubMed ID: 28538732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.
    Zhang S; Hu Y; Wu Z; Zhou X; Wu T; Li P; Lian Q; Xu S; Gu J; Chen L; Wu G; Zhang T; Tang J; Xue J
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1244-1256. PubMed ID: 36423742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Promising CPS1 Inhibitor Keeping Ammonia from Fueling Cancer.
    Taguchi A; Fahrmann JF; Hanash SM
    Cell Chem Biol; 2020 Mar; 27(3):253-254. PubMed ID: 32200911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Y-box binding protein-1 down-regulates expression of carbamoyl phosphate synthetase-I by suppressing CCAAT enhancer-binding protein-alpha function in mice.
    Chen YR; Sekine K; Nakamura K; Yanai H; Tanaka M; Miyajima A
    Gastroenterology; 2009 Jul; 137(1):330-40. PubMed ID: 19272383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding carbamoyl phosphate synthetase (CPS1) deficiency by using the recombinantly purified human enzyme: effects of CPS1 mutations that concentrate in a central domain of unknown function.
    Díez-Fernández C; Hu L; Cervera J; Häberle J; Rubio V
    Mol Genet Metab; 2014 Jun; 112(2):123-32. PubMed ID: 24813853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of carbamoyl-phosphate synthetase (CPS1) deficiency using human recombinant CPS1 as a key tool.
    Diez-Fernandez C; Martínez AI; Pekkala S; Barcelona B; Pérez-Arellano I; Guadalajara AM; Summar M; Cervera J; Rubio V
    Hum Mutat; 2013 Aug; 34(8):1149-59. PubMed ID: 23649895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CPS1: Looking at an ancient enzyme in a modern light.
    Nitzahn M; Lipshutz GS
    Mol Genet Metab; 2020 Nov; 131(3):289-298. PubMed ID: 33317798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder.
    Diez-Fernandez C; Häberle J
    Expert Opin Ther Targets; 2017 Apr; 21(4):391-399. PubMed ID: 28281899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency.
    Choi Y; Oh A; Lee Y; Kim GH; Choi JH; Yoo HW; Lee BH
    Clin Chim Acta; 2022 Feb; 526():55-61. PubMed ID: 34973183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding carbamoyl-phosphate synthetase I (CPS1) deficiency by using expression studies and structure-based analysis.
    Pekkala S; Martínez AI; Barcelona B; Yefimenko I; Finckh U; Rubio V; Cervera J
    Hum Mutat; 2010 Jul; 31(7):801-8. PubMed ID: 20578160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.